000 01453 a2200397 4500
005 20250512010724.0
264 0 _c19900201
008 199002s 0 0 eng d
022 _a0305-7453
024 7 _a10.1093/jac/24.5.787
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSteen, H J
245 0 0 _aClinical and pharmacokinetic aspects of ciprofloxacin in the treatment of acute exacerbations of pseudomonas infection in cystic fibrosis patients.
_h[electronic resource]
260 _bThe Journal of antimicrobial chemotherapy
_cNov 1989
300 _a787-95 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Oral
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aChromatography, High Pressure Liquid
650 0 4 _aCiprofloxacin
_xadverse effects
650 0 4 _aCystic Fibrosis
_xcomplications
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aPseudomonas Infections
_xdrug therapy
650 0 4 _aRespiratory Function Tests
650 0 4 _aSputum
_xmetabolism
700 1 _aScott, E M
700 1 _aStevenson, M I
700 1 _aBlack, A E
700 1 _aRedmond, A O
700 1 _aCollier, P S
773 0 _tThe Journal of antimicrobial chemotherapy
_gvol. 24
_gno. 5
_gp. 787-95
856 4 0 _uhttps://doi.org/10.1093/jac/24.5.787
_zAvailable from publisher's website
999 _c2605896
_d2605896